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Cardiac hypertrophy represents one of the most important cardiovascular problems yet the
mechanisms responsible for hypertrophic remodeling of the heart are poorly understood.
In this report we aimed to explore the molecular pathways leading to two different
phenotypes of cardiac hypertrophy in transgenic mice carrying mutations in the human
ventricular myosin essential light chain (ELC). Mutation-induced alterations in the heart
structure and function were studied in two transgenic (Tg) mouse models carrying the
A57G (alanine to glycine) substitution or lacking the N-terminal 43 amino acid residues
(43) from the ELC sequence. The first model represents an HCM disease as the A57G
mutation was shown to cause malignant HCM outcomes in humans. The second mouse
model is lacking the region of the ELC that was shown to be important for a direct
interaction between the ELC and actin during muscle contraction. Our earlier studies
demonstrated that >7 month old Tg-43 mice developed substantial cardiac hypertrophy
with no signs of histopathology or fibrosis. Tg mice did not show abnormal cardiac
function compared to Tg-WT expressing the full length human ventricular ELC. Previously
reported pathological morphology in Tg-A57G mice included extensive disorganization
of myocytes and interstitial fibrosis with no abnormal increase in heart mass observed
in >6 month-old animals. In this report we show that strenuous exercise can trigger
hypertrophy and pathologic cardiac remodeling in Tg-A57G mice as early as 3 months
of age. In contrast, no exercise-induced changes were noted for Tg-43 hearts and the
mice maintained a non-pathological cardiac phenotype. Based on our results, we suggest
that exercise-elicited heart remodeling in Tg-A57G mice follows the pathological pathway
leading to HCM, while it induces no abnormal response in Tg-43 mice.
Keywords: hypertrophic cardiomyopathy (HCM), transgenic mice, myosin essential light chain, mutation, cardiac
remodeling, histopathology
INTRODUCTION
In response to various types of stimuli (genetic, mechanical,
hemodynamic, hormonal, physiological, environmental factors
or their combination), the heart has the ability to adapt to
increased workloads through the hypertrophy of muscle cells
(Hunter and Chien, 1999; Lorell and Carabello, 2000). The hyper-
trophic response is considered physiological if the heart fully
adapts to the new loading condition, reaching a new steady state.
This type of hypertrophy is characterized by a normal organiza-
tion of cardiac structure (normal cardiac morphology), normal
or enhanced cardiac function and a relatively normal pattern of
gene expression (Bernardo et al., 2010). Hypertrophy can also be
developed as a response to physiological stimuli such as chronic
exercise. On the other hand, pathological hypertrophy is asso-
ciated with an altered pattern of gene expression, presence of
myofibrillar disarray, fibrosis, and contractile dysfunction and
thus can lead to heart failure and sudden cardiac death (SCD)
(Ho, 2010; Ho et al., 2010; Abel and Doenst, 2011). Most com-
monly hypertrophic cardiomyopathy (HCM) occurs in response
to genetic mutations in all major sarcomeric proteins, including
the myosin essential light chain (ELC) encoded by theMYL3 gene
(Alcalai et al., 2008).
There are number of studies demonstrating that physiologi-
cal and pathological cardiac hypertrophy may be associated with
distinct structural and functional as well as metabolic features
(Abel and Doenst, 2011; Weeks and McMullen, 2011). It has also
been shown that both physiologic and pathologic cardiac hyper-
trophy may display distinct biochemical and molecular signaling
pathways (Iemitsu et al., 2001; Heineke and Molkentin, 2006;
Bernardo et al., 2010). Pathological cardiac hypertrophy is man-
ifested by alterations in cardiac contractile proteins [α-skeletal
actin and the α- to β- myosin heavy chain (MHC) switch],
increased expression of fetal genes such as atrial natriuretic pep-
tide (ANP), B-type natriuretic peptide (BNP). The down- or
up-regulation of calcium handling proteins such as the cardiac
sarcoplasmic reticulum Ca2+-ATPase pump, SERCA2a can also
be observed. Physiological cardiac hypertrophy may be asso-
ciated with increased levels of peptide growth factors such as
insulin-like growth factor-IGF 1 and epidermal growth factor
and is often coupled to phosphatidylinositol 3-kinase (PI3K)/Akt
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pathway. It is known that many mutations in sarcomeric proteins
cause cardiomyopathy and may ultimately initiate the hyper-
trophic gene remodeling program. Studies utilizing transgenic
mouse models of hypertrophy are great tools for understanding
the molecular pathways responsible for different forms of car-
diac remodeling in vivo. Presented in this article study focuses
on one particular sarcomeric protein, the essential light chain of
myosin that is located in the neck region of the myosin cross-
bridge (Rayment et al., 1993), and was shown to be important
for myosin contractile function in health and in heart disease
(Sawicki et al., 2005; Kazmierczak et al., 2009, 2013; Muthu et al.,
2011; Cadete et al., 2012). Cardiac ventricular muscle exclusively
expresses the long ELC isoform, containing the N-terminal exten-
sion, which was found to be important for the myosin-actin
interaction during contraction and is expected to regulate heart
performance (Winstanley et al., 1977; Sutoh, 1982; Henry et al.,
1985; Trayer et al., 1987; Milligan et al., 1990; Morano et al.,
1995; Timson et al., 1998; Morano, 1999; Timson, 2003). The
structural modeling study by Morano (Aydt et al., 2007) depicts
the N-terminus of the long myosin ELC as a rod-like 91 Å-long
extension that can function as a bridge between the ELC core of
the myosin head and the binding site of the ELC on the actin
filament.
In this report we have studied cardiac remodeling in two forms
of cardiac hypertrophy (pathological and non-pathological)
related to the ventricular myosin ELC using transgenic mouse
models carryingmutations in the human ventricularmyosin ELC,
Tg-A57G, and Tg-43. The A57G (Alanine replaced by Glycine)
variant of ELC was found in two unrelated Korean families and
one Japanese patient diagnosed with HCM (review in Hernandez
et al., 2007). The phenotype associated with this mutation was
manifested as a classic asymmetric septal hypertrophy and SCD
(Lee et al., 2001). In the Tg-43 mouse model, the endogenous
mouse ventricular ELC is partially replaced with the 43-amino-
acid N-terminal truncated human ventricular ELC protein. We
previously reported that Tg-43 mice hypertrophied with age
(>7 month-old), but the ventricles did not show any patho-
logic morphology. In support of the non-pathologic hypertrophy
phenotype, an MRI (magnetic resonance imaging) assessment of
Tg-43 hearts demonstrated normal cardiac function compared
to age matched controls (Kazmierczak et al., 2009).
Despite intensive research in many laboratories, questions
about critical molecular mechanisms responsible for the transi-
tion from hypertrophy to heart failure still remain unanswered.
Presented here transgenicmousemodels carrying either the A57G
mutation or the 43 truncation in ELC protein, generated in our
laboratory (Kazmierczak et al., 2009, 2013; Muthu et al., 2011)
represent different types of hypertrophy and therefore are valu-
able tools in understanding the pathological vs. non-pathological
remodeling of the heart. We have examined the effects of both
A57G and 43 mutations on heart remodeling before and after
strenuous exercise and characterized the functional effects of
these mutations in mice subjected to strenuous exercise by swim-
ming. The observed effects were compared to those seen in
Tg-WT (wild-type) mice expressing the full length non-mutated
human ventricular ELC. We show that remodeling of the heart
in Tg-A57G mice follows the pathological pathway leading to
HCM, while cardiac phenotype observed in Tg-43 mice is of
non-pathological nature.
MATERIAL AND METHODS
TRANSGENIC MICE
All animal studies were conducted in accordance with institu-
tional guidelines and the protocol was reviewed and approved by
the Animal Care and Use Committee at the University of Miami
Miller School of Medicine (UMMSM). UMMSM has an Animal
Welfare Assurance (A-3224-01, effective July 11, 2007) on file
with the Office of Laboratory Animal Welfare (OLAW), National
Institutes of Health. The generation and characterization of
transgenic (Tg) mice used in this study and Tg protein expres-
sion profiles have been described earlier (Kazmierczak et al., 2009,
2013; Muthu et al., 2011). Previously produced Tg-WT lines, L1,
L3, and L4 expressing 88, 30, and 77% of WT-ELC (UniProtKB:
P08590) and Tg-A57G lines, L1, L2, and L5 expressing 80, 55, and
75% of A57G-mutant, respectively were used in this study. As for
Tg-43, two lines were used for this study, one previously gen-
erated expressing 40% of 43 protein (L9), and the second line
expressing 55% transgene which was generated by cross breeding
of existing mice (L8 × L8) in order to increase transgenic pro-
tein expression (Kazmierczak et al., 2009). The percent of protein
expression indicates the amount of replacement of the endoge-
nous mouse cardiac ELC by human ventricular WT (UniProtKB:
P08590) or its two mutants. In all experiments Tg-A57G and Tg-
43 mice were gender and age matched with Tg-WT controls
(Kazmierczak et al., 2009; Muthu et al., 2011; Kazmierczak et al.,
2013).
Chronic 4 week-long training by swimming of Tg-WT, Tg-
A57G, and Tg-43 mice was performed in water at 30–32◦C
(to avoid thermal stress). Initial swim time was set as 10min,
thereafter gradually increasing until 90min sessions were reached.
The 90-min training schedule was continued twice a day (sep-
arated by 4–5 h), 7 days a week, for 4 weeks. This protocol was
demonstrated to be highly effective in promoting physiologi-
cal hypertrophy in mice (Evangelista et al., 2003; Galindo et al.,
2009).
HISTOLOGICAL EVALUATION OF THE HEARTS FROM TRANSGENIC ELC
MICE
After euthanasia, the hearts from 3 to 5-month-old Tg-43, Tg-
A57G, and Tg-WT mice were excised, weighed and immersed in
10% buffered formalin. Slides of whole mouse hearts were pre-
pared at the Histology Laboratory (University of Miami Miller
School of Medicine, Miami FL). The paraffin-embedded longi-
tudinal sections of left ventricles (LV) of H&E (hematoxylin and
eosin) and Masson’s trichrome stained hearts were examined for
overall morphology and fibrosis using a Dialux 20 microscope,
40×/0.65 NA (numerical aperture) Leitz Wetzlar objective and an
AxioCamHRc (Zeiss) as described previously (Kazmierczak et al.,
2009, 2013; Muthu et al., 2011).
SKINNED PAPILLARY MUSCLE STRIPS FROM TRANSGENIC MICE
The papillary muscles of the left ventricles from 3 to 5 months
old Tg-A57G L1 mice, Tg-43 (L9 and inbred cross of L8) and
Tg-WT (L1, L3, and L4) mice were isolated, dissected into small
Frontiers in Physiology | Striated Muscle Physiology September 2014 | Volume 5 | Article 353 | 2
Kazmierczak et al. Animal models of cardiac hypertrophy
muscle bundles and chemically skinned in 50% glycerol and 50%
pCa 8 solution (10−8 M [Ca2+], 1mM free [Mg2+] (total MgPr
(propionate) = 3.88mM), 7mM EGTA, 2.5mM [Mg-ATP2−],
20mMMops, pH 7.0, 15mM creatine phosphate and 15 units/ml
of phosphocreatine kinase, ionic strength = 150mM adjusted
with KPr) containing 1% Triton X-100 for 24 h at 4◦C. Then
the bundles were transferred to the same solution without Triton
X-100 and stored at −20◦C for 4–6 days (Kazmierczak et al.,
2012).
STEADY-STATE FORCE MEASUREMENTS
Small muscle strips ∼1.4mm in length and 100μm in diameter
were isolated from a batch of glycerinated skinned mouse pap-
illary muscle bundles and attached by tweezer clips to the force
transducer of the Guth Muscle Research System (Heidelberg,
Germany). They were placed in a 1ml cuvette and skinned
in 1% Triton X-100 dissolved in pCa 8 buffer for 30min, as
described in Kazmierczak et al. (2012). Then they were rinsed
in pCa 8 and their length adjusted to remove the slack. This
procedure results in sarcomere length (SL) ∼2.1μm as judged
by the first order optical diffraction pattern as described in
Muthu et al. (2011); Wang et al. (2013a,b); Huang et al. (2014).
Muscle strips were then tested for steady state force develop-
ment in pCa 4 solution (composition is the same as pCa 8
buffer except the [Ca2+] = 10−4 M). All experiments were car-
ried out at 21◦C. Maximal steady state tension measured in
pCa 4 solution was expressed in Newtons per cross section
of the muscle strip (kN/m2). The measurement of diameter
was taken at ∼3 points along the muscle strip length with
an SZ6045 Olympus microscope (zoom ratio of 6.3:1, up to
189x maximum magnification) and averaged (Muthu et al.,
2012).
THE Ca2+ DEPENDENCE OF FORCE DEVELOPMENT
After the initial steady state force was determined, muscle strips
were relaxed in pCa 8 buffer and then exposed to solutions of
increasing Ca2+ concentrations from pCa 8 to 4 (Dweck et al.,
2005). Steady-state force was measured in each “pCa” solution
followed by relaxation in pCa 8 solution. Data were analyzed
using the Hill equation (Hill et al., 1980) where “[Ca2+]50 or
pCa50” is the free Ca2+ concentration which produces 50%
maximum force, and “nH” is the Hill coefficient.
ASSESSMENT OF MYOSIN CONTENT IN SEDENTARY AND EXERCISED
ANIMALS
Mouse cardiac myofibrils were prepared according to the method
described previously (Kazmierczak et al., 2013). Briefly, after
euthanasia, the hearts from 3 to 5 months old transgenic mice
were isolated and frozen in liquid nitrogen and stored at −80◦C
until processed. For the preparation of myofibrils the tissue
was thawed in the CMF (cardiac myofibril) buffer consisting
5mM NaH2PO4, 5mM Na2HPO4(pH 7.0), 0.1mM NaCl, 5mM
MgCl2, 0.5mM EGTA, 5mM ATP, 5 nM microcystin, 0.1%
Triton X-100, 20mM NaF (phosphatase inhibitor), 5mM DTT
and 1μl/ml protease inhibitor cocktail (Sigma-Aldrich Corp.,
St. Louis, MO, USA). The tissue was then homogenized in a
Mixer-Mill MM301 (Retsch) until homogenous. The homogenate
was centrifuged for 4min at 8000 g and the supernatant was
discarded. After centrifugation, the pellets were left on ice for
4min. This step was repeated three times until the pellet turned
white. The pellets were then resuspended in the CMF buffer
and the myofibrils were subsequently dissolved in Laemmli sam-
ple buffer and loaded on 15% SDS-PAGE. The thick and thin
filament proteins were detected by Coomassie brilliant blue stain-
ing. Band intensities were measured using Image J software
and ratios of total myosin regulatory light chain (RLCtot) to
tropomyosin (RLCtot./Tm) and RLCtot./TnI (troponin I) were
determined.
MYOFILAMENT PROTEIN PHOSPHORYLATION IN SEDENTARY AND
EXERCISED MICE
Mouse cardiac myofibrils were used to determine sarcomeric pro-
tein phosphorylation. After separation of the samples on 15%
SDS-PAGE Pro-Q Diamond phosphoprotein gel stain reagent
(Invitrogen) was used (as described in the manufacturer’s man-
ual) to assess phosphorylation of troponin (TnT, TnI) andmyosin
RLC. The total protein was further detected in the same gel
using the Coomassie brilliant blue staining. Myofilament protein
phosphorylation ratio (ProQ) was calculated relative to the cor-
responding Coomassie brilliant blue staining (ProQ/Coomassie)
using Image J software.
ASSESSMENT OF GENE EXPRESSION CHANGES IN THE HEARTS OF
Tg-A57G AND Tg-43 MICE
Total RNA was isolated from ventricles of sedentary and exer-
cised Tg-WT, Tg-A57G, and Tg-43 mice and converted to
double stranded cDNAs using Random Primers and a High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems)
as described earlier (Kazmierczak et al., 2009). Quantitative
PCR was conducted using SYBR Green I chemistry with gene-
specific Quantitect Primer Sets (Qiagen) for murine: ANP
(atrial natriuretic factor: NM_008725), BNP: NM_008726),
Myh6 (α-myosin heavy chain, cardiac: NM_010856), Myh7 (β-
MHC: NM_080728), ColVIIIa (collagen type 8a, NM_007739),
and ATP2a2 (NM_001110140.3) which encodes two Ca2+-
transporting ATPase isoforms, SERCA2a (cardiac) and SERCA2b
(non-muscle). SERCA2a is the predominant Ca2+ pump in
the myocardium (Vangheluwe et al., 2003). All reactions
were performed in triplicate and run using BIO-RAD iQ5
Multicolor Real-Time PCR Detection System with the fol-
lowing cycle parameters: cycle of 50◦C (2min) followed by
95◦C (10min), 40 cycles of 95◦C (15 s) followed by 60◦C
(1min). Raw data were analyzed using the BIO-RAD CFX
Manager Software, and fold change in expression of each
gene was calculated using the relative quantification (RQ)
Ct method with the levels of GAPDH (glyceraldehyde-3-
phosphate dehydrogenase: NM_008084) as the normalizer gene
(Kazmierczak et al., 2009).
STATISTICAL ANALYSIS
All data were expressed as mean ± s.e.m. Statistical compar-
isons were performed using ANOVA or independent t-test (Sigma
Plot 11; Systat Software, San Jose, CA). P-values <0.05 indicated
statistically significant differences.
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RESULTS
HISTOLOGICAL EVALUATION OF THE HEARTS FROM Tg-A57G AND
Tg-43 MICE
The evaluation performed for sedentary animals shows normal
gross morphology for all tested 3–5 month-old male mice (Tg-
WT, Tg-43, and Tg-A57G) (Figure 1A). In our earlier study
on sedentary Tg-43 mice, we observed cardiac hypertrophy in
mice ∼7 months of age while the hearts of ∼2 month-old Tg-
43 animals were indistinguishable from control Tg-WT mice
(Kazmierczak et al., 2009). As we confirmed later, the hypertro-
phy in Tg-43 mice appeared to be age dependent and profound
hypertrophy was observed in ∼12 month-old Tg-43 mice com-
pared with agematched Tg-WT hearts (Muthu et al., 2011). Thus,
the lack of abnormal heart growth observed in 3–5 month-old
sedentary Tg-43 mice (Figure 1A), is not surprising and sug-
gests that Tg-43 mice have to be at least 7 months of age
to develop cardiac hypertrophy. Regarding sedentary Tg-A57G
mice, similar to what we reported earlier (Muthu et al., 2011),
no cardiac growth could be observed in 3–5 month-old mice
(Figure 1A) or the mice as old as ∼12 months of age (Muthu
et al., 2011). However, exercised 3–5 month-old Tg-A57G ani-
mals do show cardiac hypertrophy while the hearts of Tg-43
mice were comparable in size to Tg-WT controls (Figure 1B).
Histology examination of animals subjected to strenuous exer-
cise is presented in Figure 2. H&E andMasson’s trichrome stained
left ventricular (LV) sections from Tg-43 hearts revealed that
FIGURE 1 | Gross morphology of representative hearts from ∼5
month-old sedentary (A) and ∼3 month-old exercised (B) Tg-WT,
Tg-43 and Tg-A57G male mice.
the hearts of exercised 3–5 month-old mice demonstrated no tis-
sue abnormalities, myofilament disarray or fibrosis compared to
Tg-WT controls. In contrast, the evaluation of LV heart sections
from Tg-A57G mice showed occurrences of fibrosis, especially in
the interventricular septum compartment (Figure 2). This is in
accord to previously reported pathological morphology in seden-
tary Tg-A57G mice, which included extensive disorganization of
myocytes and interstitial fibrosis (Muthu et al., 2011; Kazmierczak
et al., 2013).
SIGNALING PATHWAYS AND CHANGES IN THE GENE EXPRESSION
PROFILE IN THE HEARTS OF TWO DIFFERENT MODELS OF
HYPERTROPHY
Hypertrophic remodeling in Tg-43 and Tg-A57G animal mod-
els was studied by looking at mutation-induced alterations in
cardiac contractile proteins (α- to β-MHC switch), expression
of the fetal genes such as ANP and BNP. We also examined
whether cardiac remodeling in these mice involved changes in
the calcium handling proteins such as SERCA2a. Studies of gene
expression using real-time PCR in mouse myocardium were per-
formed for sedentary and exercised Tg animals and the results
are presented in Figures 3, 4, respectively. For sedentary Tg-
A57G mice, the expression of sarcoplasmic ATP2a2 was higher
compared with sedentary Tg-WT (∼1.6 fold). The upregulation
of mRNA SERCA2a in Tg-A57G mice (Figure 3) may trans-
late to a faster relaxation of the A57G myosin cross-bridges
and potentially lower contractile force generation in Tg-A57G
mice, what is actually observed (Figure 5A). For sedentary Tg-
43 mice the expression levels of ANP and BNP were higher
compared with sedentary Tg-WT (2- and 2.4 fold, respectively)
(Figure 3).
This upregulation of both natriuretic peptides in Tg-43 mice
most likely manifests their protective role against excessive car-
diac remodeling and preventing uncontrolled myocardial growth
of Tg-43 hearts (Tsuruda et al., 2002; Gardner, 2003).
To evaluate a combined effect of strenuous exercise and ELC
mutation on heart remodeling we have also studied the molecular
mechanisms and signaling pathways that change due to exercise.
Figure 4 presents the gene expression analysis using real-time
PCR in mouse myocardium performed for exercised Tg ELC
animals. In Tg-A57G mice the exercise training reactivated the
fetal gene program and upregulation in the β-MHC, ANP and
BNP was observed. Expression of ANP and BNP was respectively
1.9- and 2.1 fold higher compared with exercised Tg-WT (both
differences statistically significant P < 0.05). Additionally, upreg-
ulation of collagen VIIIa (1.9 fold change, significant P < 0.05)
and β-MHC (not significant) and downregulation of α-MHCwas
observed for exercised Tg-A57G compared with exercised Tg-
WT mice (Figure 4). On the other hand, exercised Tg-43 mice
showed a 0.6-fold lower expression level of ANP (P < 0.05) and
no change in BNP marker compared to exercised Tg-WT con-
trols (Figure 4). Changes in gene expression observed in Tg-A57G
mice in response to strenuous exercise represent a pathologic type
of remodeling occurring in the disease mouse model. In contrast,
lack of changes in expression levels of BNP, β-MHC and collagen
VIIIa in exercised Tg-43 mice represents an adaptive response
to exercise and non-pathological remodeling in Tg-43 animals.
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FIGURE 2 | H&E (upper panel) and Masson’s trichrome (bottom panel) stained LV sections from exercised ∼3 month-old Tg-WT, Tg-43, and
Tg-A57G male mice.
FIGURE 3 | QPCR data for sedentary ELC animals. Sedentary Tg-WT was used as a control sample (FC = 1); ∗ indicates P < 0.05 compared to sedentary
Tg-WT.
STEADY-STATE FORCE MEASUREMENTS AND Ca2+ DEPENDENCE OF
FORCE DEVELOPMENT
The data from functional measurements assessed in skinned
mouse papillary muscle strips from Tg-43 and Tg-A57G ani-
mals are presented in Figure 5, and the values of maximal force
and pCa50 are summarrized in Table 1. Different pattern of
contractile force generation and the Ca2+ sensitivity of force
was observed betweenTg-A57G and Tg-43 mice. Similar to
our earlier study (Kazmierczak et al., 2013), sedentary Tg-A57G
mice showed the lowest maximal force (∼20% lower vs. seden-
tary Tg-WT) and a slightly increased Ca2+ sensitivity of force
(pCa50 ∼=0.04 vs. sedentary Tg-WT), both changes statistically
significant. As we demonstrated earlier and in this study, seden-
tary Tg-A57G animals showed reduced maximal (pCa 4) force
and increased Ca2+ sensitivity following the pattern of patholog-
ical hypertrophy (Muthu et al., 2011; Kazmierczak et al., 2013)
(Figures 5, 6). Contrary, maximal force for sedentary Tg-43
mice was similar to that of Tg-WT and the Ca2+ sensitivity was
not changed (pCa50 ∼=0.02; not statistically significant) com-
pared to Tg-WT controls. The previously reported reduction
in steady-state force in ∼2 month-old and ∼7 month-old Tg-
43 mice (Kazmierczak et al., 2009) was likely associated with
a decrease in the myosin content observed in these animals vs.
the lack of changes in myosin expression seen in the current
investigation (Figure 7).
In response to exercise, all transgenic animals showed a higher
level of maximal force per cross-section of muscle strip vs. their
sedentary controls (Table 1). Similarly to the direction of changes
observed for sedentary animals, in response to swimming, the
maximal force for Tg-43 was similar while that for Tg-A57G
was significantly reduced (∼20% lower, P < 0.005) compared
to exercised Tg-WT. Additionally, for exercised Tg-A57G, the
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FIGURE 4 | QPCR data for exercised ELC animals. Exercised Tg-WT is used as a control sample (FC = 1); ∗ indicates P < 0.05 compared to exercised Tg-WT
mice.
FIGURE 5 | Measurements of steady-state force in skinned papillary muscle strips from sedentary and exercised transgenic ELC male mice. (A)
Maximal force assessment at pCa4. (B) Calcium sensitivity of force.
Ca2+ sensitivity of force was significantly lower compared to
sedentary Tg-A57G mice (pCa50 ∼=0.08) (Figures 5B, 6 and
Table 1). Tendency toward desensitization of myofilaments to
Ca2+ observed in Tg-A57G mice (Table 1) may represent a key
step in the signaling pathway for the pathological hypertrophic
remodeling in this animal model of HCM. As expected, there
were no significant changes in the Ca2+ sensitivity of force
between exercised and sedentary Tg-WT mice. Likewise, no sig-
nificant changes in the Ca2+ sensitivity were present between the
exercised and sedentary Tg-43 mice (Table 1). No changes in
the cooperativity (Hill coefficient) values for all groups of mice
(nH = 2.6 ± 0.3) were noted (Figure 6).
ASSESSMENT OF MYOSIN CONTENT IN SEDENTARY AND EXERCISED
ANIMALS
As mentioned above, the reduced level of maximal contractile
force measured in our previous study for sedentary Tg-43
mice was most likely associated with deficiency in myosin con-
tent detected in the myocardium of Tg-43 vs. Tg-WT mice
Table 1 | Maximal pCa 4 force and calcium sensitivity of force in
transgenic ELC skinned mouse papillary muscle strips.
System pCa50 Fmax (kN/m2)
Sedentary Tg-WT 5.629 ± 0.008 54.804 ± 1.133
Sedentary Tg-43 5.653 ± 0.010 54.581 ± 0.399
Sedentary Tg-A57G 5.673 ± 0.012 42.482 ± 1.458
Exercised Tg-WT 5.657 ± 0.012 57.731 ± 1.273
Exercised Tg-43 5.670 ± 0.011 57.421 ± 1.279
Exercised Tg-A57G 5.592 ± 0.016 47.615 ± 1.967
Data are mean ± SEM of n = 8–15 individual strips for each group of mice.
(Kazmierczak et al., 2009). Therefore, myosin content in seden-
tary and exercised animals was assessed in this study and corre-
lated with the ability of the myocardium to develop contractile
force. Figure 7 presents the ratios of RLCtot./Tm and RLCtot./TnI
determined in cardiac myofibrillar preparations from sedentary
and exercised Tg-WT, Tg-A57G, and Tg-43 mice. Compared
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to respective Tg-WT myofibrils (100%), the ratios of RLCtot./Tm
and RLCtot./TnI obtained for sedentary and exercised Tg-A57G
mice were similar to Tg-WT indicating no change in myosin
expression in all tested animals (Figure 7). Therefore, the lower
maximal force observed for the A57G mutation in this study is
not due to the lower myosin content but due to defective func-
tion of the A57G-myocardium. The values of RLCtot./Tm and
RLCtot./TnI ratios obtained for sedentary and exercised Tg-43
mice were also very similar to Tg-WT (∼110%), indicating no
previously observed deficiency of myosin in the hearts of Tg-43
animals (Kazmierczak et al., 2009).
MYOFILAMENT PROTEIN PHOSPHORYLATION IN SEDENTARY AND
EXERCISED MICE
The force-generating capacity of sarcomeres has been known
to be tightly regulated by sarcomeric proteins phosphorylation
(Sweeney et al., 1993; Sadayappan et al., 2009; Nixon et al., 2012).
To test whether the ELC mutation (43 or A57G) and/or exer-
cise had any effect on phosphorylation of sarcomeric proteins,
FIGURE 6 | The force- pCa relationship in transgenic skinned mouse
papillary muscle strips from Tg-WT, Tg-43, and Tg-A57G male mice.
we have examined phosphorylation of myosin binding protein
C (MyBP-C), Tm, troponin (TnT and TnI) and myosin RLC
in mouse cardiac myofibrils using the Pro-Q Diamond stain-
ing. As shown in Figure 8, no significant changes in endogenous
MyBP-C, Tm, TnT, TnI, or RLC phosphorylation were found in
sedentary or exercised Tg-43 or Tg-A57G animals compared to
Tg-WT mice. The lack of the effect of exercise on protein phos-
phorylation is somewhat surprising but has been observed by
other laboratories. No effect of exercise on phosphorylation of
myosin RLC in the ventricles or atria of mice was found by Fewell
et al. (1997). Likewise, no changes in phosphorylation of titin and
TnI in mice upon exercise training were recently reported by the
Granzier group (Hidalgo et al., 2014). These results suggest no
immediate molecular contacts between the ELC protein and the
phosphorylation domains of MyBP-C, Tm, TnT, TnI, or RLC.
DISCUSSION
Hypertrophic remodeling is a highly important phenomenon;
however, the molecular mechanisms and signaling pathways
underlying these processes have not yet been fully understood. In
particular, molecular pathways that play a causal role in the devel-
opment of pathological vs. physiological hypertrophy need to be
recognized due to the known association between cardiac hyper-
trophy and nearly all forms of heart failure (Levy et al., 1990).
Recognition of functional, structural, metabolic, and molecular
differences between pathological and non-pathological hypertro-
phy may help to develop potential therapeutic approaches to
benefit patients with HCM and heart failure.
REMODELING IN SEDENTARY MICE
Since the ELC is a highly essential element of the myosin
molecule, its structure and the interaction with the MHC and
actin play important roles in the sarcomeric assembly and force
production (Hernandez et al., 2007). This investigation was
designed to look at two different cardiac phenotypes induced
by structural alterations in the myosin ELC in mouse mod-
els of pathologic (Tg-A57G) and physiologic (Tg-43) HCM.
The effects of both ELC mutations on heart function and car-
diac remodeling are summarized in Figure 9. Data obtained for
FIGURE 7 | Thick and thin filament protein content in sedentary and exercised Tg-43 and Tg-A57G mice compared to control Tg-WT.
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FIGURE 8 | Assessment of protein phosphorylation in sedentary and
exercised Tg-WT, Tg-43, and Tg-A57G mouse myofibrils. MyBP-C,
myosin binding protein C; TnT, troponin T; Tm, tropomyosin; TnI, troponin I;
RLC, myosin regulatory light chain; ELCend, myosin ELC (all mouse isoforms);
ELCTg, transgenic human ELC; +P hc std, phosphorylated human cardiac
protein standard.
sedentary and exercised Tg-A57G and Tg-43 animals show clear
differences between these two phenotypes. Consistent with our
earlier reports, we monitored significantly compromised contrac-
tile function (lower maximal force and higher Ca2+ sensitivity)
in sedentary Tg-A57G mice, which coincided with upregulation
of the calcium handling protein SERCA2a compared to seden-
tary Tg-WT animals. It has been reported that in animal models,
severe compensated hypertrophy in response to pressure overload
is accompanied by a large decrease in the mRNA and protein con-
tent of SERCA2a (Buttrick et al., 1994; Rockman et al., 1994).
However, in rats with moderate cardiac hypertrophy, the level of
SERCA2a mRNA or protein was unaltered or even upregulated
(Rockman et al., 1994; Arai et al., 1996). SERCA2a is a key protein
responsible for maintaining a balanced concentration of Ca2+
during the cardiac cycle and it controls the transport of Ca2+ to
the SR during relaxation. The upregulation of mRNA SERCA2a
in Tg-A57Gmice (Figure 3) may translate to an increased protein
activity, which would lead to faster relaxation of the A57Gmyosin
cross-bridges and potentially lower contractile force generation in
Tg-A57G myocardium (Figure 5A).
These adverse effects were not present in sedentary Tg-43
mice, the model of non-pathological cardiac phenotype. The
maximal force and Ca2+ sensitivity values were similar to those
determined for sedentary Tg-WTmice, indicating a normal heart
function in Tg-43 animals. As we reported earlier (Kazmierczak
et al., 2009, 2013; Muthu et al., 2011) both mouse models demon-
strated cardiac hypertrophic growth, but the pathological features
were only observed in sedentary A57G animals (Kazmierczak
et al., 2009; Muthu et al., 2011; Kazmierczak et al., 2013).
Discrepancies exist regarding the lack of reduction in maximal
force observed in Tg-43 mice in the current study (Table 1)
and the previously reported decrease in steady-state force in Tg-
43 mice (Kazmierczak et al., 2009). The reason for a lower force
reported in Kazmierczak et al. (2009) was an approximately 30%
deficit in myosin cross-bridge content in the myocardium of Tg-
43 mice (Kazmierczak et al., 2009). This deficit in myosin con-
tent was not observed in the current work (Figure 7), indicating
a compensatory response in transgenic Tg-43 mice over time.
Consequently, the lack of abnormalities in myosin expression was
most likely responsible for no changes in force per cross-section
of muscle seen in Tg-43 mice in the current investigation
(Table 1). Additionaly, recently published data utilizing the same
Tg-43 mouse model, showed only a slight (and not signifi-
cant) decrease in maximal tension between Tg-WT and Tg-43
(Michael et al., 2013; Wang et al., 2013a).
Sedentary Tg-43 mice also showed an upregulation of ANP
and BNP (Figure 3). Upregulation of these transcripts is consid-
ered a highly conserved feature of ventricular hypertrophy (Lee
et al., 1988; Dagnino et al., 1992; Buttrick et al., 1994; Nakagawa
et al., 1995), but there are contradictory reports in the litera-
ture on the correlation of upregulation of natriuretic peptides
with physiological hypertrophy that can be induced by vari-
ous training programs in animals. Some publications report an
upregulation (Buttrick et al., 1994; Allen et al., 2001), while some
report no change (Azizi et al., 1995; Jin et al., 2000) or down-
regulation (Diffee et al., 2003) of ANP and/or BNP expression
in these animal models. Both natriuretic peptides were shown to
function asmodulators of cardiac hypertrophy preventing uncon-
trolled myocardial growth and regulating ventricular remodeling
secondary to compensatory hypertrophy (Tsuruda et al., 2002;
Gardner, 2003). It is therefore possible that in the case of seden-
tary Tg-43 mice, mild upregulation of ANP and BNP manifests
their protective role against excessive cardiac remodeling and
controlling the extent of cardiac hypertrophy.
There are some discrepancies between our earlier study and
current investigation on the hypertrophic growth in sedentary
Tg-43mice. In Kazmierczak et al. (2009), we presented the gross
morphology images of young (∼2 mo-old) and adult (∼7 mo-
old) Tg-43 animals. The hypertrophy was only noted for the
older animals. The hearts of young Tg-43 mice were indistin-
guishable from age matched control Tg-WT mice. In the current
study, the hearts of 3–5 month-old sedentary Tg-43 mice were
not much different than those of age matched Tg-WT controls
(Figure 1A). These data suggest that hypertrophy in Tg-43mice
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FIGURE 9 | Molecular effects of A57G and 43 mutations in the
myosin ELC on heart morphology and function and expression of
hypertrophic markers in sedentary and exercised Tg ELC mice. All
data are compared with either sedentary or exercised Tg-WT ELC. The
in vivo data were published previously. LVV, LV-volume; CO, cardiac
output; SW, stroke work; LVEDV, LV-end diastolic volume; Ees, measure
of myocardial contractility defined by the slope of the end-systolic
pressure-volume relationship.
is an age dependent process and the fact that it was not present
in <5 month-old Tg-43 animals (Figure 1A), i.e., ∼2 months
before the apparent threshold when the animals reach∼7 months
of age (Kazmierczak et al., 2009) is not surprising. In line with
this, a profound hypertrophy in ∼12 month-old Tg-43 mice
was recently reported by our group (Muthu et al., 2011).
REMODELING IN EXERCISED MICE
Swimming exercise is known for its efficiency in inducing car-
diac hypertrophy and significant increases in LV end-diastolic
volumes in rats (Geenen et al., 1988). We hypothesized that
strenuous exercise applied to Tg-43 and Tg-A57G mice would
lead to differential cardiac remodeling in these animal models
displaying two distinct phenotypes of a “healthy” (43) vs. “dis-
eased” (A57G) heart. Our data on exercised animals confirmed
our hypothesis. For Tg-A57G animals, we observed a signifi-
cant upregulation of hypertrophic markers that were activated
upon exercise initiating pathological hypertrophic remodeling in
Tg-A57G mice (Figure 9). Upregulation of ANP and BNP tran-
scripts observed in exercised Tg-A57G mice (Figure 4) manifests
their sensitivity in monitoring ventricular hypertrophy (Lee et al.,
1988; Dagnino et al., 1992; Nakagawa et al., 1995). ANP and
BNP are released by the heart usually in response to heart fail-
ure (cardiac injury). The BNP levels in plasma have been shown
to be useful in monitoring therapy for heart failure and typically
a good response to effective treatment correlates with decreased
concentrations of BNP (Lee et al., 2002; Yoshimura et al., 2002).
Upregulation of ANP, BNP, and Collagen VIIIa was paralleled
by a visible increase in heart size in Tg-A57G mice (Figure 1B),
manifesting pathological hypertrophic remodeling in Tg-A57G
mice (Figure 9).
Force generation and the Ca2+ sensitivity of force in Tg-
A57G mice were significantly reduced after strenuous excise
(Tables 1, 2) manifesting pathological hypertrophic remodeling.
Although maximal force in these animals was slightly improved
compared to sedentary mice it was still significantly lower than
that monitored for other exercised mice. It is possible that stren-
uous exercise caused activation of the β-adrenergic pathway in
Tg-A57G hearts that could lead to compromised heart perfor-
mance. Decreased Ca2+ sensitivity in these animals compared
to sedentary Tg-A57G mice might be indicative of progress-
ing toward heart failure as observed in animal models of HF
(Cazorla et al., 2005; Belin et al., 2007) and in humans (Van Dijk
et al., 2009; Hoskins et al., 2010; Sequeira et al., 2013; Witjas-
Paalberends et al., 2013). The presence of collagen deposits in the
myocardium of Tg-A57G mice (Figure 2) indicates the propen-
sity of the heart to increase its LV stiffness that ultimately may
result in diastolic dysfunction in Tg-A57G mice (Wu et al., 2007).
A different response on the strenuous exercise was observed
for the second Tg-43 animal model. Function of the heart
remained normal and both maximal force and the Ca2+ sensitiv-
ity were similar to exercised Tg-WT mice. Additionally, exercised
Tg-43 animals showed similar pattern of gene expression to that
observed in exercised Tg-WT mice, indicating that hypertrophic
remodeling of the heart was no longer present in this animal
model. The lack of changes in expression levels of BNP, β-MHC,
www.frontiersin.org September 2014 | Volume 5 | Article 353 | 9
Kazmierczak et al. Animal models of cardiac hypertrophy
Table 2 | Statistics for measurements of steady-state force in skinned
papillary muscle strips from sedentary and exercised transgenic ELC
animals.
Statistics (P-value)
Tg-WT ELC Tg-43 Tg-A57G
pCa50
Sedentary WT vs. mutant N/A 0.0676 0.0049
Exercised WT vs. mutant N/A 0.4212 0.0037
Sedentary vs. exercised 0.0601 0.2488 0.0008
F max
Sedentary WT vs. mutant N/A 0.8580 <0.0001
Exercised WT vs. mutant N/A 0.8648 0.0002
Sedentary vs. exercised 0.0970 0.0437 0.0466
and collagen VIIIa in exercised Tg-43 mice represents an adap-
tive response to exercise and non-pathological remodeling in Tg-
43 animals compared to detrimental heart remodeling observed
in exercised Tg-A57G mice.
CONCLUSIVE REMARKS
Our previous X-ray studies on sedentary Tg-A57G and Tg-43
mice demonstrated a mutation-induced decrease in the fila-
ment lattice spacing in skinned papillary muscles of Tg-A57G
compared to Tg-WT controls (Muthu et al., 2011). These struc-
tural changes may initiate hypertrophic remodeling of the heart
triggered by mutation-induced conformational changes within
the sarcomere that lead to abnormal interaction of two major
contractile proteins, myosin and actin causing abnormalities in
contractile force production and heart performance. Pathological
ventricular remodeling and anatomical changes observed in Tg-
A57G hearts mostly develop in older animals and, as we antici-
pated, they were augmented in response to strenuous exercise. In
contrast, X-ray diffraction studies on Tg-43 mice demonstrated
a shift of cross-bridge mass from the thick filament backbone
toward the thin filaments and no changes in the interfilament
spacing compared with Tg-WT controls (Muthu et al., 2011).
These data indicate that the lack of the N-terminal ELC extension
in Tg-43 animals may lead to changes in myosin head orienta-
tion positioning it closer (at smaller angle) to the actin filaments
(Muthu et al., 2011). The important function of the N-terminal
extension of the ELC protein was also demonstrated in other
study showing that the length-dependent activation in Tg-43
strips was blunted in Tg-43 animals (Michael et al., 2013). This
could eventually lead to hypertrophy in Tg-43 animals but of
the non-pathological nature.
Combined knowledge of the genetic basis of HCM with
biophysical and transcriptional analyses may help to better under-
stand the pathophysiology of heart remodeling and make pre-
dictive correlations between the specific mutations with disease
prognosis. The heart may tolerate various types of stimuli, but
compensatory/adaptive responses that aim to maintain function
may fail in case of patients with pre-existing HCM (hearts with
disease-causing mutations), resulting in a wide range of func-
tional deficits and/or cardiomyopathy. The strenuous exercise
of competitive athletes has been known to make symptoms of
HCMmore apparent and because of the risk of SCD during exer-
cise, HCM patients are excluded from most competitive sports
(Michels et al., 2009). Our data confirm that it is reasonable to
caution people with diagnosed genetic HCM against intensive
exercise programs. Our previous and current studies suggest that
the A57G mutation can initiate pathologic cardiac remodeling
and drive the heart toward cardiomyopathy disease and/or heart
failure while the 43–dependent pathway displays a tendency
toward a non-pathological cardiac phenotype.
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